» Dizziness
» Nausea
» Rash
ZENBEXUS requires medical supervision
The SFDA emphasised that ZENBEXUS needs to be used below specialised medical supervision.
Sufferers receiving the drugs ought to have their medical situation and blood take a look at outcomes monitored frequently, in response to the authorised prescribing leaflet.
SFDA Breakthrough Drugs Program
ZENBEXUS was beforehand designated below the SFDA’s Breakthrough Drugs Program.
This system covers medicines which have:
• Accomplished medical growth.
• Demonstrated promising efficacy and security.
• Proven a transparent therapeutic impact for severe illnesses.
This system seeks to expedite affected person entry to specialised therapies, broaden the vary of therapies on supply and to allow earlier entry to modern medicine through a quicker approval course of.
Supporting Saudi Imaginative and prescient 2030 and healthcare transformation
The approval of ZENBEXUS demonstrates the SFDA’s ongoing dedication to innovation and growing entry to cutting-edge remedy choices in Saudi Arabia.
The authority added that these efforts assist in bettering the standard of well being care and supporting the targets of the Well being Sector Transformation Program, which is likely one of the key initiatives below Saudi Imaginative and prescient 2030. Learn: 46,900 new firms established in Saudi Arabia throughout H1 2026
SFDA works to supply sufferers with entry to specialised therapies at an earlier stage and lead the transformation of the healthcare sector in Saudi Arabia through applications such because the Breakthrough Drugs Program and the approval of modern therapies, together with ZENBEXUS.
